Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway
2019 ◽
Keyword(s):
2020 ◽
Vol 75
(4)
◽
pp. 621
◽